Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3125 of 3284 entries
View as:

National Survey on Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00804167 Org: User:
Start: 12/31/08 End: 07/31/09 Due: 07/31/10

Study to Investigate Safety, Tolerability and PK Following Single and Multiple Ascending Doses of AZD7295 in Japanese

Phase: N/A Priority: Normal
NCT ID: NCT00818129 Org: User:
Start: 12/31/08 End: 05/31/09 Due: 05/31/10

TrinetX Study of Hypereosinophilic Syndrome (HES) Without an Identifiable Non-haematological Secondary Cause

Phase: N/A Priority: Normal
NCT ID: NCT06172751 Org: User:
Start: 12/15/23 End: 04/26/24 Due: 04/26/25

Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong Kong

Phase: N/A Priority: Normal
NCT ID: NCT03519958 Org: User:
Start: 09/30/18 End: 11/30/20 Due: 11/30/21

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone

Phase: N/A Priority: Normal
NCT ID: NCT01434186 Org: User:
Start: 05/31/12 End: 04/30/16 Due: 04/30/17

hATTR Polyneuropathy in Russia

Phase: N/A Priority: Normal
NCT ID: NCT06365593 Org: User:
Start: 12/29/23 End: 05/30/24 Due: 05/30/25

A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders

Phase: N/A Priority: Normal
NCT ID: NCT00642811 Org: User:
Start: 05/31/08 End: 03/31/09 Due: 03/31/10

An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT01019161 Org: User:
Start: 11/30/09 End: 06/30/10 Due: 06/30/11

A Study to Evaluate the Safety, Tolerability and Absorption to the Blood After Administration of Single and Multiple Doses of AZD8154 in Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT03436316 Org: User:
Start: 07/26/18 End: 07/29/19 Due: 07/29/20

Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT00521365 Org: User:
Start: 05/31/08 End: 08/31/09 Due: 08/31/10

Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5

Phase: N/A Priority: Normal
NCT ID: NCT00652002 Org: User:
Start: 07/31/02 End: 01/31/04 Due: 01/31/05

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis

Phase: N/A Priority: Normal
NCT ID: NCT04631016 Org: User:
Start: 12/14/20 End: 11/13/23 Due: 11/13/24

A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05205161 Org: User:
Start: 07/05/22 End: 08/17/23 Due: 08/17/24

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

Phase: N/A Priority: Normal
NCT ID: NCT00516802 Org: User:
Start: 01/31/07 End: 01/31/09 Due: 01/31/10

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications

Phase: N/A Priority: Normal
NCT ID: NCT01107886 Org: User:
Start: 05/31/10 End: 05/31/13 Due: 05/31/14

Durvalumab Long-Term Safety and Efficacy Study

Phase: N/A Priority: Normal
NCT ID: NCT04078152 Org: User:
Start: 09/05/19 End: 10/31/24 Due: 10/31/25

Investigation of Rate + Extent of Excretion of Radioactivity in Urine +Faeces After Oral Administration of [14C]AZD2066

Phase: N/A Priority: Normal
NCT ID: NCT00829088 Org: User:
Start: 01/31/09 End: 02/28/09 Due: 02/28/10

Brazilian Reality of Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06230328 Org: User:
Start: 04/15/24 End: 11/14/24 Due: 11/14/25

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04588727 Org: User:
Start: 10/15/20 End: 01/19/22 Due: 01/19/23

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

Phase: N/A Priority: Normal
NCT ID: NCT01395550 Org: User:
Start: 01/31/10 End: 07/31/10 Due: 07/31/11

Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records

Phase: N/A Priority: Normal
NCT ID: NCT06842056 Org: User:
Start: 03/15/25 End: 03/31/30 Due: 03/31/31

AZD2115 Multiple Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT01445782 Org: User:
Start: 10/31/11 End: 07/31/12 Due: 07/31/13

IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04854590 Org: User:
Start: 04/22/21 End: 07/25/23 Due: 07/25/24

Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX

Phase: N/A Priority: Normal
NCT ID: NCT00590213 Org: User:
Start: 06/30/03 End: - Due: -

The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01205269 Org: User:
Start: 10/31/10 End: 12/31/10 Due: 12/31/11